Stromal Tumor-Infiltrating Lymphocyte Levels Are Associated With Immune Checkpoint Proteins In Triple Negative Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
Clinical trial NCT06965361 · COMPLETED
Trial details
- NCT number
- NCT06965361
- Sponsor
- Ziauddin University
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-01-02
- Primary completion
- 2022-07-31
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.